Rita Bellagamba

2.2k total citations
50 papers, 1.2k citations indexed

About

Rita Bellagamba is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Rita Bellagamba has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 26 papers in Virology and 19 papers in Emergency Medicine. Recurrent topics in Rita Bellagamba's work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (25 papers) and HIV/AIDS Research and Interventions (21 papers). Rita Bellagamba is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (25 papers) and HIV/AIDS Research and Interventions (21 papers). Rita Bellagamba collaborates with scholars based in Italy, United States and Lebanon. Rita Bellagamba's co-authors include Andrea Antinori, Valerio Tozzi, Pietro Balestra, Pasquale Narciso, Angela Corpolongo, Simonetta Galgani, Marinella Giulianelli, Ubaldo Visco‐Comandini, Chrysoula Vlassi and Pasquale Narciso and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Rita Bellagamba

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita Bellagamba Italy	19	871	782	497	196	101	50	1.2k
Kunling Wu United States	17	916 1.1×	797 1.0×	884 1.8×	274 1.4×	135 1.3×	39	1.6k
Véronique Schiffer Netherlands	16	663 0.8×	613 0.8×	426 0.9×	290 1.5×	102 1.0×	43	1.2k
Valerio Tozzi Italy	21	1.2k 1.4×	1.2k 1.5×	637 1.3×	281 1.4×	117 1.2×	40	1.7k
Scott Letendre United States	9	843 1.0×	587 0.8×	443 0.9×	163 0.8×	134 1.3×	14	1.0k
James L. K. Fletcher United States	20	1.0k 1.2×	849 1.1×	431 0.9×	319 1.6×	74 0.7×	32	1.3k
Lucy Garvey United Kingdom	17	506 0.6×	421 0.5×	276 0.6×	204 1.0×	92 0.9×	38	826
Aylin Yilmaz Sweden	24	876 1.0×	1.1k 1.4×	361 0.7×	256 1.3×	227 2.2×	68	1.8k
Judith Schouten Netherlands	15	541 0.6×	413 0.5×	637 1.3×	197 1.0×	53 0.5×	17	1.0k
Anupa Kamat United States	11	917 1.1×	483 0.6×	475 1.0×	218 1.1×	216 2.1×	14	1.2k
Pietro Balestra Italy	12	936 1.1×	683 0.9×	549 1.1×	158 0.8×	140 1.4×	17	1.1k

Countries citing papers authored by Rita Bellagamba

Since Specialization

Citations

This map shows the geographic impact of Rita Bellagamba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Bellagamba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Bellagamba more than expected).

Fields of papers citing papers by Rita Bellagamba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Bellagamba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Bellagamba. The network helps show where Rita Bellagamba may publish in the future.

Co-authorship network of co-authors of Rita Bellagamba

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Bellagamba. A scholar is included among the top collaborators of Rita Bellagamba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Bellagamba. Rita Bellagamba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cicalini, Stefania, Simone Lanini, Roberta Gagliardini, et al.. (2024). Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study. Pharmaceuticals. 17(12). 1706–1706. 1 indexed citations

Mastrorosa, Ilaria, Massimo Tempestilli, Stefania Notari, et al.. (2021). Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons. European Journal of Drug Metabolism and Pharmacokinetics. 47(1). 135–142. 1 indexed citations

Tempestilli, Massimo, Ilaria Mastrorosa, Stefania Notari, et al.. (2017). Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world. Journal of Antimicrobial Chemotherapy. 73(1). 160–164. 2 indexed citations

Volpe, Massimo, Antonella Castagna, Cristina Mussini, et al.. (2017). Cardiovascular disease in women with HIV-1 infection. International Journal of Cardiology. 241. 50–56. 15 indexed citations

Zaccarelli, Mauro, Maria Mercedes Santoro, Daniele Armenia, et al.. (2016). Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. Journal of Clinical Virology. 82. 94–100. 28 indexed citations

Latini, Alessandra, Massimiliano Fabbiani, Vanni Borghi, et al.. (2016). Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study. BMC Infectious Diseases. 16(1). 401–401. 5 indexed citations

Maggi, Paolo, Vincenzo Montinaro, Cristina Mussini, et al.. (2015). Novel antiretroviral drugs and renal function monitoring of HIV patients.. PubMed. 16(3). 144–51. 33 indexed citations

Libertone, Raffaella, Patrizia Lorenzini, Pietro Balestra, et al.. (2014). Central nervous system penetration‐effectiveness rank does not reliably predict neurocognitive impairment in HIV‐infected individuals. Journal of the International AIDS Society. 17(4S3). 19655–19655. 9 indexed citations

Focà, Emanuele, Davide Motta, Marco Borderi, et al.. (2012). Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infectious Diseases. 12(1). 38–38. 35 indexed citations

10.

Nardo, Pasquale De, Angela Corpolongo, Rita Bellagamba, et al.. (2012). Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report. Infectious Agents and Cancer. 7(1). 15–15. 7 indexed citations

11.

Albini, Laura, Bruno Mario Cesana, Davide Motta, et al.. (2011). A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 18–24. 34 indexed citations

12.

Narciso, Pasquale, Raffaella Bucciardini, Valerio Tozzi, et al.. (2009). Immediate versus Delayed Surgical Intervention for Reconstructive Therapy of HIV-Associated Facial Lipoatrophy: A Randomized Open-Label Study. AIDS Research and Human Retroviruses. 25(10). 979–987. 6 indexed citations

13.

Tozzi, Valerio, Rita Bellagamba, Filippo Castiglione, et al.. (2008). Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART. AIDS Research and Human Retroviruses. 24(6). 787–796. 4 indexed citations

14.

Svicher, Valentina, Stefano Aquaro, Roberta D’Arrigo, et al.. (2008). Specific Enfuvirtide‐Associated Mutational Pathways in HIV‐1 Gp41 Are Significantly Correlated With an Increase in CD4⁺Cell Count, Despite Virological Failure. The Journal of Infectious Diseases. 197(10). 1408–1418. 35 indexed citations

15.

Nicastri, Emanuele, Lucia Palmisano, Loredana Sarmati, et al.. (2008). HIV-1 Residual Viremia and Proviral DNA in Patients with Suppressed Plasma Viral Load ( < 400 HIV-RNA cp/ml) During Different Antiretroviral Regimens. Current HIV Research. 6(3). 261–266. 27 indexed citations

16.

D’Arrigo, Roberta, Massimo Ciccozzi, Caterina Gori, et al.. (2007). gp41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure. AIDS Research and Human Retroviruses. 23(10). 1296–1302. 8 indexed citations

17.

Tozzi, Valerio, Pietro Balestra, Rita Bellagamba, et al.. (2007). Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 174–182. 242 indexed citations

18.

Giancola, Maria Letizia, Patrizia Lorenzini, Pietro Balestra, et al.. (2006). Neuroactive Antiretroviral Drugs Do Not Influence Neurocognitive Performance in Less Advanced HIV-Infected Patients Responding to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(3). 332–337. 49 indexed citations

19.

Tozzi, Valerio, Pietro Balestra, Diego Serraino, et al.. (2005). Neurocognitive Impairment and Survival in a Cohort of HIV-Infected Patients Treated with HAART. AIDS Research and Human Retroviruses. 21(8). 706–713. 94 indexed citations

20.

Zaccarelli, Mauro, Carlo Federico Perno, Federica Forbici, et al.. (2004). Q151M‐Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy. Clinical Infectious Diseases. 38(3). 433–437. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact